First, scientists use engineered immune cells to send an autoimmune disease into remission

Five patients with hard-to-treat lupus went into remission after scientists changed their immune cells using a technique commonly used to treat cancer. After the single therapy, all five patients with autoimmune disease stopped their standard treatments and did not relapse.

This treatment, known as chimeric antigen receptor (CAR) T-cell therapy, needs to be tested in larger groups of lupus patients before it can be approved for widespread use. But if the results hold up in larger studies, the therapy could someday offer relief to people with moderate to severe lupus.

Leave a Comment

Your email address will not be published.